Correction: ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The correction refers to the completion of the auditor's remark and ODI Pharma's comment which is now included in the press release. The...
top of page
News
Please find below news from ODI Pharma AB. More stock relevant news can be found in the section "Stock Information" on the "INVESTORS" site.
Suche
ODI Pharma
- vor 3 Tagen
- 2 Min.
Rättelse: ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
Rättelsen avser komplettering av revisorns anmärkning och ODI Pharmas kommentar som nu finns inkluderat i pressmeddelandet. Bifogad...
ODI Pharma
- vor 6 Tagen
- 3 Min.
ODI Pharma AB: Publication of interim report report Q1 2023/2024
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2023 – September 2023. The report is...
ODI Pharma
- vor 6 Tagen
- 1 Min.
ODI Pharma AB publishes the annual report for the fiscal year 2022/2023
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
- vor 6 Tagen
- 1 Min.
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2022/2023
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2022/2023....
ODI Pharma
- vor 7 Tagen
- 1 Min.
ODI Pharma AB postpones publication of interim report and annual report until November 24, 2023
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2023/2024 and the...
ODI Pharma
- 13. Nov.
- 5 Min.
Notice to Annual General Meeting in ODI Pharma AB (publ)
The shareholders of ODI Pharma AB (publ), 559223–1392, are hereby invited to attend the Annual General Meeting on Friday, 15th of...
ODI Pharma
- 13. Nov.
- 4 Min.
Kallelse till årsstämma i ODI Pharma AB (publ)
Aktieägarna i ODI Pharma AB (publ), 559223–1392, kallas härmed till årsstämma fredagen den 15 december 2023 kl. 10.30 i bolagets lokaler...
ODI Pharma
- 24. Aug.
- 4 Min.
ODI Pharma AB: Publication of year-end report for the fiscal year 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its year-end report for the period July 2022 – June 2023. The report is available...
ODI Pharma
- 7. Aug.
- 3 Min.
ODI Pharma AB enters into exclusive collaboration with Synoptis Pharma Sp. z o.o.
ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has entered through its Polish subsidiary into a collaboration...
ODI Pharma
- 1. Juni
- 2 Min.
ODI Pharma AB receives loan financing of EUR 350,000
ODI Pharma AB (“ODI” or “the Company”) hereby announces that the Company has secured loan financing of EUR 350,000 from an external...
ODI Pharma
- 25. Mai
- 3 Min.
ODI Pharma AB: Publication of interim report report Q3 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report for the period July 2022 – March 2023. The report is available...
ODI Pharma
- 23. Feb.
- 3 Min.
ODI Pharma AB: Publication of half-year report 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2022. The report is available...
ODI Pharma
- 24. Jan.
- 2 Min.
ODI Pharma receives approval from the Office for Registration of Medicinal Products in Poland
ODI Pharma AB (“ODI” or the “Company”) announces today that the Company has received approval from the Office for Registration of...
ODI Pharma
- 16. Dez. 2022
- 2 Min.
Announcement from the Annual General Meeting in ODI Pharma AB (publ)
This is an unofficial translation of a notice to the Annual General Meeting in ODI Pharma AB (publ), originally drafted in Swedish. In...
ODI Pharma
- 16. Dez. 2022
- 2 Min.
Kommuniké från årsstämma i ODI Pharma AB (publ)
Idag den 16 december 2022 hölls årsstämma i ODI Pharma AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga...
ODI Pharma
- 25. Nov. 2022
- 3 Min.
ODI Pharma AB: Publication of interim report Q1 2022/2023
ODI Pharma AB (“ODI” or the “Company”) hereby publishes its interim report concerning the period July 2022 to September 2022. The report...
ODI Pharma
- 25. Nov. 2022
- 1 Min.
ODI Pharma AB publishes the annual report for the fiscal year 2021/2022
The Board of Directors and the Chief Executive Officer of ODI Pharma AB (“ODI Pharma”) hereby publishes the annual report for the fiscal...
ODI Pharma
- 25. Nov. 2022
- 1 Min.
ODI Pharma AB publicerar årsredovisning för räkenskapsåret 2021/2022
Styrelsen och verkställande direktören för ODI Pharma AB (”ODI Pharma”) publicerar härmed årsredovisningen för räkenskapsåret 2021/2022....
ODI Pharma
- 24. Nov. 2022
- 1 Min.
ODI Pharma AB postpones publication of interim report and annual report until November 25, 2022
ODI Pharma AB (“ODI” or the “Company”) stated in its year-end report that the interim report for the first quarter of 2022/2023 and the...
bottom of page